The impact of neoadjuvant chemotherapy on 30-day radical cystectomy outcomes.

被引：0
|
作者：
Wang, Kerith Ruoyao
Simhal, Rishabh
Shah, Yash
Ragam, Radhika
Simon, Daniel P.
Mark, James Ryan
Gomella, Leonard G.
Lallas, Costas D.
Shah, Mihir S.
机构：
[1] Thomas Jefferson Univ, Dept Urol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Urol, Philadelphia, PA 19107 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4594
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of Navigation on 30-Day Outcomes for Adult Spinal Deformity Surgery
    Katz, Austen D.
    Galina, Jesse
    Song, Junho
    Hasan, Sayyida
    Perfetti, Dean
    Virk, Sohrab
    Silber, Jeff
    Essig, David
    GLOBAL SPINE JOURNAL, 2023, 13 (07) : 1728 - 1736
  • [42] Urethral recurrence following radical cystectomy: Risk factors and outcomes.
    Khanna, Abhinav
    Zganjar, Andrew
    Shah, Paras
    Tollefson, Matthew K.
    Karnes, Jeffrey R.
    Sharma, Vidit
    Tarrell, Robert F.
    Thapa, Prabin
    Thompson, Houston R.
    Frank, Igor
    Boorjian, Stephen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [43] Longer time to radical cystectomy in patients treated with neoadjuvant chemotherapy is associated with worse oncological outcomes
    Nuijens, Siberyn T.
    van Osch, Frits H. M.
    van Hoogstraten, Lisa M. C.
    Witjes, J. Alfred
    Aben, Katja K. H.
    Hermans, Tom J. N.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (04) : 117.e11 - 117.e16
  • [44] Outcomes of PTO at radical cystectomy without neoadjuvant therapy
    Ayyathurai, Rajinikanth
    Luongo, Tony
    Nieder, Alan M.
    Manoharan, Murugesan
    Soloway, Mark S.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 552 - 552
  • [45] DETERMINING THE OPTIMAL TIMING FOR RADICAL CYSTECTOMY AFTER NEOADJUVANT CHEMOTHERAPY
    Mmeje, Chinedu
    Benson, Cooper
    Nogueras-Gonzalez, Graciela
    Jayaratna, Isuru
    Navai, Neema
    Gao, Jianjun
    Siefker-Radtke, Arlene
    Kamat, Ashish
    Dinney, Colin
    Shah, Jay
    JOURNAL OF UROLOGY, 2015, 193 (04): : E808 - E809
  • [46] Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy
    Brimo, Fadi
    Downes, Michelle R.
    Jamaspishvili, Tamara
    Berman, David
    Barkan, Guliz A.
    Athanazio, Daniel
    Abro, Schuharazad
    Visram, Kash
    Yilmaz, Asli
    Solanki, Shraddha
    Hahn, Elan
    Siemens, Robert
    Kassouf, Wassim
    Trpkov, Kiril
    HISTOPATHOLOGY, 2018, 73 (05) : 732 - 740
  • [47] Refining Patient Selection for Neoadjuvant Chemotherapy before Radical Cystectomy
    Culp, Stephen H.
    Dickstein, Rian J.
    Grossman, H. Barton
    Pretzsch, Shanna M.
    Porten, Sima
    Daneshmand, Siamak
    Cai, Jie
    Groshen, Susan
    Siefker-Radtke, Arlene
    Millikan, Randall E.
    Czerniak, Bogdan
    Navai, Neema
    Wszolek, Matthew F.
    Kamat, Ashish M.
    Dinney, Colin P. N.
    JOURNAL OF UROLOGY, 2014, 191 (01): : 40 - 47
  • [48] Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy
    Mmeje, Chinedu O.
    Benson, Cooper R.
    Nogueras-Gonzalez, Graciela M.
    Jayaratna, Isuru S.
    Gao, Jianjun
    Siefker-Radtke, Arlene O.
    Kamat, Ashish M.
    Dinney, Colin P.
    Navai, Neema
    Shah, Jay B.
    BJU INTERNATIONAL, 2018, 122 (01) : 89 - 98
  • [49] REFINING PATIENT SELECTION FOR NEOADJUVANT CHEMOTHERAPY PRIOR TO RADICAL CYSTECTOMY
    Culp, Stephen
    Dickstein, Rian
    Pretzsch, Shanna
    Navai, Neema
    Wszolek, Matthew
    Siefker-Radtke, Arlene
    Kamat, Ashish
    Dinney, Colin
    JOURNAL OF UROLOGY, 2012, 187 (04): : E770 - E770
  • [50] Impact of care fragmentation in patients receiving neoadjuvant chemotherapy and radical cystectomy for bladder cancer.
    Riveros, Carlos
    Chalfant, Victor
    Balaji, K. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345